Skip to Main Content

Avian Influenza

Current U.S. Bird Flu Situation in Humans

H5N1 Bird Flu: Current Situation
Last Updated: February 24, 2025

Confirmed and probable cases are typically updated by 5 PM EST on Mondays (for cases confirmed by CDC on Friday, Saturday, or Sunday), Wednesdays (for cases confirmed by CDC on Monday or Tuesday), and Fridays (for cases confirmed by CDC on Wednesday and Thursday). Affected states may report cases more frequently.


Confirmed human case summary since 2024, by state and exposure source
  Exposure Associated with Commercial Agriculture & Related Operations      
State Dairy Herds (Cattle) Poultry Farms & Culling Operations Other Animal Exposure Exposure Source Unknown State Total
California 36 0 0 2 38
Colorado 1 9 0 0 10
Iowa 0 1 0 0 1
Louisiana 0 0 1 0 1
Michigan 2 0 0 0 2
Missouri 0 0 0 1 1
Nevada 1 0 0 0 1
Ohio 0 1 0 0 1
Oregon 0 1 0 0 1
Texas 1 0 0 0 1
Washington 0 11 0 0 11
Wisconsin 0 1 0 0 1
Wyoming 0 0 1 0 1
Source Total 41 24 2 3 70

NOTE: One additional case was previously detected in a poultry worker in Colorado in 2022. Louisiana reported the first H5 bird flu death in the U.S.


Probable human case summary during the 2024 outbreak, by state and exposure source

When a case tests positive for H5 at a public health laboratory but testing at CDC is not able to confirm H5 infection, per Council of State and Territorial Epidemiologists (CSTE) guidance, a case is reported as probable.

Commercial Poultry Exposure: Probable Cases
  • Washington - 3
  • Arizona - 2
Commercial Dairy Cattle Exposure: Probable Cases
  • California - 1
Unknown Source Exposure: Probable Cases
  • Delaware - 1

Confirmed and probable cases are typically updated by 5 PM EST on Mondays (for cases confirmed by CDC on Friday, Saturday, or Sunday), Wednesdays (for cases confirmed by CDC on Monday or Tuesday), and Fridays (for cases confirmed by CDC on Wednesday and Thursday). Affected states may report cases more frequently.

H5N1 Genetic Analyses

CDC Technical Summaries: Human H5N1 Genetic Analyses
 
Genetic Sequences of Highly Pathogenic Avian Influenza A(H5N1) Viruses Identified in a Person in Louisiana
December 26, 2024

This is a technical summary of an analysis of the genomic sequences of the viruses identified in two upper respiratory tract specimens from the patient who was severely ill from an infection with highly pathogenic avian influenza (HPAI) A(H5N1) virus in Louisiana. CDC has sequenced the influenza viruses in specimens collected from the patient in Louisiana who was infected with, and became severely ill from HPAI A(H5N1) virus. The genomic sequences were compared to other HPAI A(H5N1) sequences from dairy cows, wild birds and poultry, as well as previous human cases and were identified as the D1.1 genotype. The analysis identified low frequency mutations in the hemagglutinin gene of a sample sequenced from the patient, which were not found in virus sequences from poultry samples collected on the patient’s property, suggesting the changes emerged in the patient after infection.

The genomes of the virus (A/Louisiana/12/2024) from each clinical specimen are publicly posted in GISAID (EPI_ISL_19634827 and EPI_ISL_19634828) and GenBank (PQ809549-PQ809564).

 

Summary Analysis of the Genetic Sequence of a Highly Pathogenic Avian Influenza A(H5N1) Virus Identified in a Child in California
December 10, 2024

This is a technical summary of an analysis of the genomic sequence data for an influenza A(H5N1) virus from a pediatric case in California that was confirmed by CDC on November 22. Although the genetic data generated were insufficient to classify the virus as a specific genotype, the virus gene segments sequenced most closely resemble those segments from recent B3.13 viruses detected in California in humans, dairy cattle and poultry.

CDC and Stanford Medicine have submitted these data for A/California/192/2024 to both the GISAID and GenBank databases with accession numbers EPI_ISL_19597300 and PQ724471-PQ724473, respectively.

 

Summary Analysis of the Genetic Sequence of a Highly Pathogenic Avian Influenza A(H5N1) Virus Identified in a Human in Michigan
May 24, 2024

CDC has sequenced the influenza virus genome identified in a conjunctival specimen collected from the person in Michigan who was identified to be infected with HPAI A(H5N1) virus and compared each gene segment with HPAI A(H5N1) sequences from cows, wild birds and poultry and the first human case in Texas. The virus HA was identified as clade 2.3.4.4b with each individual gene segment closely related to genotype B3.13 viruses detected in dairy cows available from USDA testing. No amino acid changes were identified in the HA gene sequence from the Michigan patient specimen compared to the HA sequence from the case in Texas and only minor changes were identified when compared to sequences from cows. These data indicate viruses detected in both cows and the two human cases maintain primarily avian genetic characteristics and lack changes that would make them better adapted to infect or transmit between humans. The genome of the human virus from Michigan did not have the PB2 E627K change detected in the virus from the Texas case but had one notable change (PB2 M631L) compared to the Texas case that is known to be associated with viral adaptation to mammalian hosts, and which has been detected in 99% of dairy cow sequences but only sporadically in birdsA. This change has been identified as resulting in enhancement of virus replication and disease severity in mice during studies with avian influenza A(H10N7) virusesB. The remainder of the genome of A/Michigan/90/2024 was closely related to sequences detected in infected dairy cows and strongly suggests direct cow-to-human transmission.

 

The genome of the virus identified from the patient in Michigan (A/Michigan/90/2024) is publicly posted in GISAID (EPI_ISL_19162802) and has been submitted to GenBank (PP839258-PP839265).

 

Summary Analysis of Genetic Sequences of Highly Pathogenic Avian Influenza A(H5N1) Viruses in Texas
April 2, 2024

CDC has sequenced the influenza virus genome identified in a specimen collected from the patient in Texas who was confirmed to be infected with highly pathogenic avian influenza A(H5N1) ["HPAI A(H5N1)"] virus and compared these with HPAI A(H5N1) sequences from cattle, wild birds and poultry. The virus sequences are HA clade 2.3.4.4b HPAI A(H5N1) with each individual gene segment closely related to viruses detected in dairy cattle available from USDA testing in Texas. While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and for the most part lack changes that would make them better adapted to infect mammals. The genome for the human isolate had one change (PB2 E627K) that is known to be associated with viral adaptation to mammalian hosts, and which has been detected before in people and other mammals infected with HPAI A(H5N1) virus and other avian influenza subtypes (e.g., H7N9), but with no evidence of onward spread among people. 

The genome of the virus identified from the patient in Texas is publicly posted in GISAID and has been submitted to GenBank.


2025 Human H5N1 Cases: Genetic Analyses

As of February 24, CDC has confirmed three human cases of H5 bird flu in people who became ill in 2025: a dairy worker with exposure to infected dairy cows (Nevada), a poultry worker with exposure to infected commercial poultry (Ohio), and the owner of an infected backyard poultry flock (Wyoming). These are all considered higher-risk exposures. While the dairy worker was not hospitalized, both people with poultry exposures experienced severe illness and were hospitalized. Both hospitalized cases were confirmed positive from lower respiratory specimens, including a bronchoalveolar lavage and sputum. To date, there has been no evidence of onward spread from any of these people to anyone else.

 

Nevada Dairy Worker

The dairy worker in Nevada had conjunctivitis (eye redness and irritation) and has recovered. Most infections associated with U.S. dairy cows to date have involved mild respiratory symptoms or conjunctivitis. This person was exposed to infected dairy cows and tested positive for avian influenza A(H5N1) virus.

CDC's analysis of the genetic sequence of the virus isolated from the patient in Nevada identified the virus as an avian influenza A(H5N1) virus from clade 2.3.4.4.b (genotype D1.1). The nucleotide sequence was nearly identical to that of the viruses that USDA reported from dairy cows in Nevada that the person worked with. The virus had a genetic mutation in its polymerase basic 2 (PB2) protein that has previously been associated with more efficient virus replication in mammalian cells (i.e., change of PB2 D701N). This change was previously identified in a human case in Chile in 2023

 
Ohio Poultry Worker

The poultry worker in Ohio had respiratory symptoms and is home and recovering. This person participated in culling activities on a farm with infected poultry. The initial upper respiratory specimens could not be confirmed as positive for avian influenza A(H5) virus at CDC, so CDC initially reported this as a probable case; a subsequent specimen from the person was confirmed positive for avian influenza A(H5) virus at CDC.

Sequencing data are not yet available for the Ohio case.

 

Wyoming Backyard Flock Owner

The backyard flock owner in Wyoming had respiratory symptoms and is reported to have underlying health conditions that can make people more vulnerable to severe influenza illness. This person has been discharged from the hospital and is recovering. This person had direct contact with poultry infected with avian influenza A(H5) virus that died on their property. Initial upper respiratory specimens were negative for influenza viruses; a lower respiratory specimen collected several days later in the hospital was positive for avian influenza A(H5N1) virus.

CDC's analysis of the genetic sequence of the virus from the patient in Wyoming identified an avian influenza A(H5N1) virus from clade 2.3.4.4.b (genotype D1.1). The virus had a genetic mutation in its PB2 protein that has previously been associated with more efficient virus replication in people and other mammals (i.e., change of PB2 E627K). This change was previously identified in a human case in Texas during 2024

H5 Monitoring & Surveillance in Humans

National Flu Surveillance

The CDC has multiple surveillance systems that monitor national, state, and local level influenza data, including:

  • Influenza virus and illness activity are monitored year-round through a collaborative effort between CDC and many partners, including state, local, and territorial health departments; public health and clinical laboratories; clinics; and emergency departments.

  • Human cases of novel influenza, which are human infections with non-human influenza A viruses that are different from currently spreading seasonal human influenza viruses, are nationally notifiable. Every identified case is investigated and reported to CDC.
  • CDC is actively looking at multiple flu indicators during the current situation to monitor for influenza A(H5N1) viruses, including looking for spread of the virus to, or among people, in jurisdictions where the virus has been identified in people or animals.

This data is used year-round to monitor key flu indicators. These data are reviewed comprehensively each week.

Weekly Snapshot for the Week Ending: February 21, 2025

Case Reporting

5 cases detected through national flu surveillance

Public Health Laboratory Monitoring Since February 25, 2024, 136,134+ specimens tested using a protocol that would have detected influenza A(H5) or other novel influenza viruses
Clinical Laboratory Trends

CDC has not identified any unusual trends in reported clinical laboratory data at the national, state, or local levels.

Emergency Departments

CDC has not identified any unusual trends in emergency department visits associated with influenza or potentially related symptoms at the national, state, or local levels.

Wastewater Surveillance For the week ending February 15, 2025, 360 sites reported results for avian influenza A(H5) in wastewater, and 12 (3.3%) sites from 3 states (California, Connecticut, New Jersey) reported H5 detections.

Targeted H5 Surveillance

CDC numbers are based on weekly state aggregate reports since 2022. CDC defers to states for updated information on people being monitored and tested. March 24, 2024, was the date of the first reported dairy cow infections in the United States.

February 2022 - Present

CDC and state and local health departments monitor people exposed to infected birds, poultry, dairy cows or other animals for 10 days after exposure. Between February 2022 and now, there have been:

  • At least 24,500 people monitored and 
  • At least 1,120 people tested for novel influenza A 
Current HPAI Outbreak (2024) CDC and state and local health departments monitor people exposed to infected birds, poultry, dairy cows and other animals for 10 days after exposure.  Between March 24, 2024, and now, there have been:

  • At least 15,200 people monitored 
    • At least 8,900 with exposures to dairy cows
    • At least 6,300 with exposures to birds and other animals including poultry (non-dairy cow source)
  • At least 830 persons tested for novel influenza A
    • At least 217 with exposures to dairy cows
    • At least 620 with exposures to birds and other animals including poultry (non-dairy cow source)

66 human cases detected through targeted H5 surveillance 

H5N1 in New York

New York State Department of Health Advisory

DATE: February 3, 2025
FROM: New York State Department of Health (NYSDOH), New York City Department of Health and Mental Hygiene (NYCDOHMH)

 

Accelerated Subtyping of Influenza A in Hospitalized Patients

Please see the below Health Advisory from the Centers for Disease Control and Prevention (CDC) regarding accelerated subtyping for influenza A specimens among hospitalized individuals testing positive for influenza.

Although the ongoing global outbreak of highly pathogenic avian influenza A(H5N1) virus has primarily affected dairy cows, poultry, and other animals, 66 human cases (including one death) have been identified in the United States in 2024. CDC is now recommending ordering subtyping for all influenza A-positive specimens collected from hospitalized individuals within 24 hours of hospital admission to help rapidly detect any human cases of avian influenza A(H5N1).

 
New York clinicians should:
  1. Ask people with suspected or confirmed influenza about potential exposures to wild and domestic animals, animal products, or symptomatic people with probable or confirmed avian influenza A(H5).
  2. Implement appropriate infection control measures when influenza is suspected.
    • If avian influenza A(H5) is suspected, place the individual in an airborne infection isolation room (AIIR) with negative pressure, with standard, contact, and airborne precautions. If none is available, place a facemask on the individual and isolate in an examination room with the door closed. The individual should not be placed in any room where room exhaust is recirculated without high-efficiency particulate air (HEPA) filtration.
  3. Test for influenza A in all hospitalized people with suspected seasonal influenza or avian influenza A(H5) virus infection, using whatever diagnostic test is most readily available for initial diagnosis.
    • If the initial diagnostic test cannot subtype, order a seasonal influenza A subtyping diagnostic test within 24 hours of hospital admission for those who tested positive for influenza A.
      • The two main types of seasonal influenza A subtypes are H1 and H3. If a specimen tests positive for one of these subtypes, H5 testing is not needed, unless exposure history suggests H5 infection.
      • Seasonal influenza A subtyping tests (e.g., respiratory pathogen panel with fluA(H1)/(H3) analytes) can be performed in one of the following settings:
        • Hospital clinical laboratory
        • Commercial clinical laboratory
        • Public health laboratories, if seasonal influenza A subtyping is not feasible through in-house or commercial testing.
    • If preliminary seasonal influenza subtyping yields an unsubtypeable result, samples should be promptly submitted to a public health laboratory for further characterization and potential H5 testing.
    • If exposure history or symptoms strongly suggest H5 infection, submit specimens to a public health laboratory for characterization in lieu of seasonal subtyping, in line with previous guidance.